ENZYGNOST + ANTI-CMV IGG TEST— 510(k) K852478

Substantially Equivalent

Behring Diagnostics, Inc.

FDA 510(k) clearance K852478 for ENZYGNOST + ANTI-CMV IGG TEST, Substantially Equivalent on 1985-09-16. Applicant: Behring Diagnostics, Inc..

Clearance details

Applicant: Behring Diagnostics, Inc.
Product code: Code LFZ
Advisory panel: Microbiology
Date received: 1985-06-11
Decision date: 1985-09-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: La Jolla, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.